Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

CERUS CORPORATION

Filed by INNOVATIVE FEDERAL STRATEGIES, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 20, 2026
Income
$40,000.00
Expenses
Not reported
Filing UUID
78c27625-70f7-4687-80ae-b321cc622677
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

H.R.____/S.____ Department of Defense Appropriations Bill, 2027, Title VI, all provisions related to blood safety. H.R.____/S.____ Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, 2027 - Title II, all provisions related to blood safety.

DEF · Defense

H.R.____/S.____ National Defense Authorization Act, 2027, Title XIV, all provisions related to blood safety.

HCR · Health Issues

Contacted officials regarding the Red Blood Cell Clinical Trial Program and blood safety issues.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.